Further, p21 (CDKN1A), a key effector of TP53, has been shown inhibited in some HCL cases through mutation of its transcription factor KLF2 or overexpression of its regulatory microRNA [16–18]. The gene discussed is TP53; the disease is hairy cell leukemia.